Russell Investments Group, Ltd. Century Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$2.46 - $4.05 $7,355 - $12,109	2,990 Added 104.84%	5,842 $14,000
Q4 2023 Feb 05, 2024	BUY	$1.28 - $3.32 $3,033 - $7,868	2,370 Added 491.7%	2,852 $9,000
Q3 2023 Nov 13, 2023	SELL	$2.0 - $3.23 $3,786 - $6,114	-1,893 Reduced 79.71%	482 $0
Q3 2022 Nov 04, 2022	SELL	$8.57 - $13.1 $7,995 - $12,222	-933 Reduced 28.2%	2,375 $23,000
Q2 2022 Jul 29, 2022	BUY	$7.96 - $12.43 $26,331 - $41,118	3,308 New	3,308 $27,000

36.9M

8.7K

10.2K

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $71.2M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.